SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 14F1 - Statement regarding change in majority of directors [Rule 14f-1]:
SEC Accession No. 0000930413-08-002993
Filing Date
2008-05-09
Accepted
2008-05-09 17:26:45
Documents
1

Document Format Files

Seq Description Document Type Size
1 c53490_sc14f1.txt SC 14F1 89005
  Complete submission text file 0000930413-08-002993.txt   91381
Mailing Address 5360 NORTHWEST 35TH AVENUE FT. LAUDERDALE FL 33309
Business Address 5360 NORTHWEST 35TH AVENUE FT. LAUDERDALE FL 33309 954-486-4590
Synovics Pharmaceuticals (Filed by) CIK: 0001030839 (see all company filings)

IRS No.: 860760991 | State of Incorp.: NV | Fiscal Year End: 1031
Type: SC 14F1
SIC: 2833 Medicinal Chemicals & Botanical Products
Assistant Director 1

Mailing Address 5360 NORTHWEST 35TH AVENUE FT. LAUDERDALE FL 33309
Business Address 5360 NORTHWEST 35TH AVENUE FT. LAUDERDALE FL 33309 954-486-4590
Synovics Pharmaceuticals (Subject) CIK: 0001030839 (see all company filings)

IRS No.: 860760991 | State of Incorp.: NV | Fiscal Year End: 1031
Type: SC 14F1 | Act: 34 | File No.: 005-51883 | Film No.: 08819822
SIC: 2833 Medicinal Chemicals & Botanical Products
Assistant Director 1